Outcomes in patients on home haemodialysis in England and Wales, 1997–2005: a comparative cohort analysis
Nitsch, Dorothea, Steenkamp, Retha, Tomson, Charles R.V., Roderick, Paul, Ansell, David and Macgregor, Mark S. (2010) Outcomes in patients on home haemodialysis in England and Wales, 1997–2005: a comparative cohort analysis. Nephrology, Dialysis, Transplantation (doi:10.1093/ndt/gfq561 ).
Full text not available from this repository.
Background: The UK national policy promotes expansion of home haemodialysis, but there are no recent data on characteristics and outcomes of a national home haemodialysis population.
Methods: We compared incident home haemodialysis patients in England and Wales (n = 225, 1997–2005) with age- and sex-matched incident peritoneal dialysis, hospital haemodialysis and satellite haemodialysis patients with follow-up until 31 December 2006. Cox regression analyses included time-dependent changes of wait-listing for transplantation (a proxy for health status), start of home haemodialysis and transplantation.
Results: There was a median delay of 12 months between starting renal replacement therapy (RRT) and home haemodialysis. During that first year of RRT, > 50% of home haemodialysis patients were wait-listed for kidney transplantation; hospital haemodialysis patients had a lower rate of wait-listing over time [hazard ratio (HR) 0.56, 95% confidence interval (CI) 0.44–0.70; P < 0.001]. In crude analyses, there was a marked survival advantage of home haemodialysis patients compared with other modalities (log-rank P-value < 0.001). In adjusted analyses, being on home haemodialysis yielded a long-term survival benefit compared with peritoneal dialysis (HR 0.61, 95% CI 0.40–0.93), and a borderline advantage compared with hospital haemodialysis (HR 0.68, 95% CI 0.44–1.03). There was no evidence of an advantage compared with satellite haemodialysis (HR 0.94, 95% CI 0.65–1.37).
Conclusions: Home haemodialysis patients have better survival compared with other dialysis modalities. Some of this crude survival advantage is due to selection of a healthier patient cohort as evidenced by higher transplant wait-listing rates. The advantage over peritoneal dialysis persisted after adjustment for wait-listing and transplantation over time.
|Subjects:||H Social Sciences > HA Statistics
R Medicine > RC Internal medicine
|Divisions:||University Structure - Pre August 2011 > School of Medicine > Community Clinical Sciences
|Date Deposited:||21 Sep 2010 09:27|
|Last Modified:||07 Jun 2011 08:39|
|Contributors:||Nitsch, Dorothea (Author)
Steenkamp, Retha (Author)
Tomson, Charles R.V. (Author)
Roderick, Paul (Author)
Ansell, David (Author)
Macgregor, Mark S. (Author)
|Date:||14 September 2010|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)